{
  "id": 483765,
  "title": "Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses",
  "url": "https://urgent.news/2026/08/10/scribes-benjamin-oakes-on-a-rare-ipo-and-bringing-crispr-to-the-masses",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-10T14:25:05.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/scribe-gene-editing-ipo-benjamin-oakes-epigenetic-pcsk9/827432/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The CEO spoke with BioPharma Dive about convincing investors to buy into the first gene editing IPO in more than two years.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}